多重基因疗法作为调节参与新血管与年龄相关的黄斑变性相关分子表达的工具
1Department of Biomedicine, Hoegh Guldbergs Gade 10, Aarhus University, 8000, Aarhus C, Denmark; Department of Ophthalmology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.
Progress in retinal and eye research
|December 13, 2024
概括
基因疗法为视网膜疾病 (如新血管与年龄相关的黄斑变性) 提供了一种有希望的替代方案,而不是重复注射. 多目标基因疗法,减少血管内皮生长因子 (VEGF) 和增加色素表皮衍生因子 (PEDF),显示出复杂疾病的潜力.
科学领域:
- 眼科医生 眼科 眼科
- 基因治疗 基因治疗
- 视网膜疾病 视网膜疾病
背景情况:
- 目前针对新血管与年龄相关的黄斑变性 (nAMD) 的抗血管内皮生长因子 (VEGF) 疗法需要频繁的视内注射,反应可变.
- 需要新的治疗方式,为视网膜疾病提供更少,更有效的干预措施.
研究的目的:
- 审查当前的知识,技术,局限性和基因疗法的未来方向,用于获得和衰老的视网膜疾病.
- 突出新型基因疗法的发展,包括使用腺相关病毒 (AAV) 载体的单个和多目标方法.
主要方法:
- 对视网膜疾病的基因治疗现有文献的综述.
- 开发腺相关病毒 (AAV) 载体,用于针对VEGF和PEDF的基因疗法.
主要成果:
- 基因疗法提供了一种替代重复的内注射.
- 开发出用于降低VEGF和调高色素表皮衍生因子 (PEDF) 表达的AAV载体.
- 建议用于复杂的视网膜疾病,如干性AMD (dAMD),糖尿病黄斑 (DME) 和视网膜静脉封闭 (RVO).
结论:
- 基因疗法,特别是多目标疗法,对那些对当前治疗反应不足的患者具有显著的前景.
- 需要进行进一步的临床研究,以确定在诊断时将从基因疗法中受益最多的患者子组.
更多相关视频
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
2.0K
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
1.0K
相关概念视频
Gene Therapy
25.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.2K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
